ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Collaboration Key to 3D Bioprinting Stem Cell Research Success at BioFab3D@ACMD in Australia – 3DPrint.com

3DPrint.comCollaboration Key to 3D Bioprinting Stem Cell Research Success at BioFab3D@ACMD in Australia3DPrint.comMedical researchers and scientists have created all kinds of medical marvels, from brain tissue and cartilage to a heart and a pancreas, b… Continue reading

2017-08-31 Michael Zand NEWS

Oxford BioMedica could pocket $100m on Novartis CAR-T cell success – BioPharma-Reporter.com

Continue reading

2017-08-31 Michael Zand NEWS

Penn Medicine & CHOP were instrumental in developing ‘breakthrough’ gene therapy – LancasterOnline

Oxford BioMedica could pocket $100m on Novartis CAR–T cell success
BioPharma-Reporter.com
The US approval of the first autologous chimeric antigen receptor (CAR) T cell therapy Kymriah (tisagenlecleucel) has been heralded as a historic moment in cancer treatment, and at a price of $475,000 (€400,000) for a one-time infusion, is set to …

Continue reading

2017-08-31 Michael Zand NEWS

Penn Medicine & CHOP were instrumental in developing ‘breakthrough’ gene therapy – LancasterOnline


LancasterOnline

Penn Medicine & CHOP were instrumental in developing ‘breakthrough’ gene therapy
LancasterOnline
The Food and Drug Administration has approved the first treatment that genetically engineers patients’ own blood cells into an army of assassins to seek and destroy childhood leukemia. Here’s a look at how the powerful CAR-T cell therapy works. (Aug. 30).
FDA approves new gene therapy treatment for leukemia developed by Penn Medicine and CHOPFOX43.com

all 2 news articles »

Continue reading

2017-08-31 Michael Zand NEWS

‘Gentler’ CRISPR sheds light on autoimmune disease – FierceBiotech


LancasterOnline

Penn Medicine & CHOP were instrumental in developing ‘breakthrough’ gene therapy
LancasterOnline
The Food and Drug Administration has approved the first treatment that genetically engineers patients’ own blood cells into an army of assassins to seek and destroy childhood leukemia. Here’s a look at how the powerful CAR-T cell therapy works. (Aug. 30).
FDA approves new gene therapy treatment for leukemia developed by Penn Medicine and CHOPFOX43.com

all 2 news articles »

Continue reading

2017-08-31 Michael Zand NEWS

‘Gentler’ CRISPR sheds light on autoimmune disease – FierceBiotech

‘Gentler’ CRISPR sheds light on autoimmune disease
FierceBiotech
CRISPR is typically used to edit disease-causing gene mutations, but is increasingly being tapped for broader applications. The latest? Identifying sequences that activate genes, which could help unravel the causes of autoimmune disease. While CRISPR …

Continue reading

2017-08-31 Michael Zand NEWS

Promising One-of-a-kind Clinical Trial Adds Immunotherapy to Colorectal Cancer Treatment Protocol – Markets Insider

‘Gentler’ CRISPR sheds light on autoimmune disease
FierceBiotech
CRISPR is typically used to edit disease-causing gene mutations, but is increasingly being tapped for broader applications. The latest? Identifying sequences that activate genes, which could help unravel the causes of autoimmune disease. While CRISPR …

Continue reading

2017-08-31 Michael Zand NEWS

Beta blockers capable of reducing stress signaling may enhance effectiveness of immunotherapy – News-Medical.net

Promising One-of-a-kind Clinical Trial Adds Immunotherapy to Colorectal Cancer Treatment Protocol
Markets Insider
The clinical trial adds an additional component to the pre-surgery radiation/chemotherapy regimen – immunotherapy. It is administered in the form of daily pills for two weeks prior to radiation and chemotherapy, and then during that treatment as well.

and more »

Continue reading

2017-08-31 Michael Zand NEWS
  • 1
  • …
  • 1,269
  • 1,270
  • 1,271
  • 1,272
  • 1,273
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Beta blockers capable of reducing stress signaling may enhance effectiveness of immunotherapy
News-Medical.net
While the development of therapies designed to block “checkpoints” within the immune system has been one of the most exciting and noteworthy advances in cancer research in recent years, it’s also been one of the most puzzling, leaving researchers to …

and more »